CSL Ltd Balance Sheet Analysis
ASX:CSL
Health Care
•
Biotechnology
Balance Sheet
Comprehensive analysis of CSL Ltd's financial position
| Items | 2024 | 2025 | |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 1.7B | 2.2B | |
| Short-term Investments | 157M | - | |
| Accounts Receivable | 2.6B | 3.1B | |
| Inventories | 6.0B | 6.5B | |
| Total Current Assets | 10.8B | 11.9B | |
| Non-Current Assets | |||
| Property, Plant & Equipment (Net) | 9.7B | 8.3B | |
| Investments | 163M | - | |
| Intangible Assets | 8.3B | 16.2B | |
| Goodwill | 8.1B | - | |
| Total Non-Current Assets | 27.3B | 27.6B | |
| Total Assets | 38.0B | 39.4B | |
| Current Liabilities | |||
| Short-term Debt & Overdrafts | 944M | 804M | |
| Trade Payables | 867M | 3.5B | |
| Total Current Liabilities | 5.0B | 4.8B | |
| Non-Current Liabilities | |||
| Long-term Debt | 11.2B | 10.7B | |
| Total Non-Current Liabilities | 13.7B | 13.2B | |
| Total Liabilities | 18.6B | 18.0B | |
| Shareholders' Equity | |||
| Share Capital | 371M | 574M | |
| Retained Earnings | 16.0B | 17.7B | |
| Total Shareholders' Equity | 17.3B | 21.4B | |
| Total Liabilities & Equity | 38.0B | 39.4B |
Note: Fiscal year ends in June. All amounts are in the original currency (AUD). Values displayed in millions (M) or billions (B) where applicable. Negative amounts shown in red parentheses.